Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia

Journal of Medical Genetics

Volumn 40, Issue 12, 2003, Pages 865-871

  Harrison, R E ^a   Flanagan, J A ^a   Sankelo, M ^b   Abdalla, S A ^c   Rowell, J ^a   Machado, R D ^a   Elliott, C G ^d   Robbins, I M ^e   Olschewski, H ^f   McLaughlin, V ^g   Gruenig, E ^h   Kermeen, F ⁱ   Laitinen, T ^b   Morrell, N W ^j   Halme, M ^k   Raisanen Sakolowski ^k   Trembath, R C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d LDS HOSPITAL   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f JUSTUS LIEBIG UNIVERSITY   (Germany)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ FLINDERS MEDICAL CENTRE   (Australia)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; ENDOGLIN; PHOSPHOTRANSFERASE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL LINE; CELL SURFACE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER MODEL; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DNA SEQUENCE; ENDOPLASMIC RETICULUM; EXON; FAMILY; FEMALE; FUNCTIONAL ASSESSMENT; GENE CONSTRUCT; GENE OVEREXPRESSION; HEALTH CARE FACILITY; HELA CELL; HUMAN; HUMAN CELL; HYDROGEN BOND; MALE; MEDICAL SPECIALIST; MISSENSE MUTATION; MOLECULAR GENETICS; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE; SEQUENCE ANALYSIS;

ANIMALIA;

EID: 9144219585     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.40.12.865     Document Type: Article

References (30)

1. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-51.
2. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteus ME, Marchuk DA. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-95.
3. Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 1993;75:671-80.
4. Pece-Barbara N, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 1999;274:584-94.
5. International PPH Consortium: Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA, Loyd JE, Nichols WC, Trembath RC. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 2000;26:81-4.
6. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikiv S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, Knowles JA. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000;67:737-44.
7. Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, Ward K, Yacoub M, Mikhail G, Rogers P, Newman J, Wheeler L, Higenbottam T, Gibbs JS, Egan J, Crozier A, Peacock A, Allcock R, Corris P, Loyd JE, Trembath RC, Nichols WC. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 2000;37:741-5.
8. Humbert M, Deng Z, Simonneau G, Barst RJ, Sitbon O, Wolf M, Cuervo N, Moore KJ, Hodge SE, Knowles JA, Morse JH. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Resp J 2002;20:518-23.
9. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
10. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Galie N, Loyd JE, Humbert M, Nichols WC, Morrell NW, Berg J, Manes A, McGaughran J, Pauciolo M, Wheeler L. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:325-34.
11. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann O, Kjeldsen AD, Plauch H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66-7.
12. Abdalla SA, Pece-Barbara N, Vera S, Tapia E, Paez E, Bernabeu C, Letarte M. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet 2000;9:1227-37.
13. Berg JN, Gallione CJ, Stenzel TT, Johnson DW, Allen WP, Schwartz CE, Jackson CE, Porteus ME, Marchuk DA. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 1997;61:60-7.
14. Abdalla SA, Cymerman U, Johnson RM, Deber CM, Letarte M. Disease-associated mutations in conserved residues of ALK-1 kinase domain. Eur J Hum Genet 2003;11:279-87.
15. Kjeldsen AD, Brusgaard K, Poulson L, Kruse T, Rasmussen K, Green A, Vase P. Mutations in the ALK-1 gene and the phenotype of hereditary hemorrhagic telangiectasia in two large Danish families. Am J Med Genet 2001;98:298-302.
16. Lin WD, Wu JY, Hsu HB, Tsai FJ, Lee CC, Tsai CH. Mutation analysis of a family with hereditary hemorrhagic telangiectasia associated with hepatic arteriovenous malformation. J Formos Med Assoc 2001;100:817-19.
17. Klaus DJ, Gallione CJ, Anthony K, Yeh EY, Yu J, Lux A, Johnson DW, Marchuk DA. Novel missense and frameshift mutations in the activin receptor-like kinase-1 gene in hereditary hemorrhagic telangiectasia. Mutations in brief no. 164. Online. Hum Mutat 1998;12:137.
18. McDonald JE, Miller FJ, Hallam SE, Nelson L, Marchuk DA, Ward KJ. Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. Am J Med Genet 2000;93:320-7.
19. Olivieri C, Mira E, Delu G, Pagella F, Zambelli A, Malvezzi L, Buscarini E, Danesino C. Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary haemorrhagic telangiectasia. J Med Genet 2002;39:E39.
20. Sapru RP, Hutchinson DC, Hall JI. Pulmonary hypertension in patients with pulmonary arteriovenous fistulae. Br Heart J 1969;31:559-69.
21. van den Driesche S, Mummery CL, Westermann CJ. Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. Cardiovasc Res 2003;58:20-31.
22. Garamszegi N, Dore JJ, Penheiter SG, Edens M, Yao D, Leof EB. Transforming growth factor beta receptor signaling and endocytosis are linked through a CCOH terminal activation motif in the type I receptor. Mol Biol Cell 2001;12:2881-93.
23. Huse M, Chen YG, Massague J, Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell 1999;96:425-36.
24. Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massague J. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. Mol Cell 2001;8:671-82.
25. Rudarankanchana N, Flanagan JA, Chen H, Utpon PD, Machado RD, Patel D, Trembath RC, Morrell NW. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 2002;11:1-9.
26. Porteous ME, Burn J, Proctor SJ. Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 1992;29:527-30.
27. Abdalla SA, Geisthoff UW, Bonneau D, Plauchu H, McDonald J, Kennedy S, Faughnan ME, Letarte M. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. J Med Genet 2003;40:494-502.
28. Loyd JE, Primm RK, Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis 1984;129:194-7.
29. Thomas AQ, Gaddipati R, Newman JH, Loyd JE. Genetics of primary pulmonary hypertension. Clin Chest Med 2001;22:477-91.
30. Lehmann K, Seemann P, Stricker S, Sammar M, Meyer B, Süring K, Majewski F, Tinschert S, Grzeschik K, Müller A, Knaus P, Nürnberg P, Mundlos S. Mutations in bone morphogenic protein receptor 1B cause brachydactyly type A2. Proc Natl Acad Sci USA 2003;100:12277-82.